Izotropic

Izotropic FCF/Debt

The Free Cash Flow to Debt Ratio of Izotropic (IZO.CN) as of Oct 20, 2026 is -38.25 %.

FCF/Debt

-38.25 %

Last updated:

Free Cash Flow to Debt Ratio of Izotropic is 2017 -38.25 % . Free Cash Flow to Debt Ratio of Izotropic was 2016 - . It decreases by % lower compared to the previous year.

The Izotropic FCF/Debt history

The Izotropic FCF/Debt history
YEARFCF/DebtYoY
-38.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Izotropic Stock analysis

What does Izotropic do? Izotropic Corp, based in Surrey, British Columbia, commercializes proprietary diagnostic products for breast cancer. The company, listed on 31 May 2018, develops IzoView, a CT imaging system for non-invasive tissue characterization, initially targeting breast imaging. Despite being publicly traded, the firm has not yet generated revenue. Izotropic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Izotropic stock

Free Cash Flow to Debt Ratio of Izotropic is -38.25 % in 2017.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Izotropic since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Izotropic with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Izotropic

All Key Metrics — Izotropic